Wednesday, March 31, 2021
via Zoom from Vantage Venues’ Toronto Studio

8:30am  Welcome and Introductions – Karen Azlen, CEO, Introduction Capital
8:45am – 9:35am Rob Goodall – President, CEO and Founder, Canadian Mortgage Capital Corporation
9:40am – 10:30am Kent Willmore – President, AGinvest Farmland Properties Canada
10:35am – 11:25am Gil Aharon – Co-founder and Portfolio Manager, Rosalind Advisors
11:25am – 11:30am  Closing Remarks – Karen Azlen

Introduction Capital presents its first Manager Showcase, a virtual event offering investors and colleagues in our network an opportunity to hear from three best-in-class Canadian alternative investment managers.  Principals from AGinvest Farmland Properties Canada, CMCC Capital Funds, and Rosalind Advisors will each speak about the establishment of their respective firms as well as provide an overview of their fund investment strategy, performance history and an explanation of the benefits of their chosen asset class.  Each presentation will be followed by a moderated Q & A session.
 
This is a “cap intro” showcase sponsored by Introduction Capital in order to generate awareness and investor interest in any or all of the funds presenting.  Registrants may be contacted for follow-up to determine interest levels in investing.

Rob Goodall

President, CEO and Founder
Canadian Mortgage Capital Corporation
Real Estate

Robert Goodall is the President and founder of Canadian Mortgage Capital Corporation (‘CMCC’), a company that has two primary activities: (i) managing the operations of Atrium Mortgage Investment Corporation, a $700 million non-bank lender which trades on the TSX, and (ii) managing various private real estate funds, totaling over $280 million in equity, that invest with major developers across Canada. CMCC’s head office is in downtown Toronto, and the company has 2 branch offices in western Canada. In its history, CMCC has arranged financing on over $6 billion of real estate in Ontario and funded more than $2.5 billion of loans and equity investments across Canada.

Prior to founding CMCC, Mr. Goodall spent seven years with Royal Trust, where the last three years were served as National Managing Director of the Real Estate Finance Group with a portfolio of $1.4 billion in commercial and multi-residential real estate loans. Mr. Goodall is a trustee of two publicly held REITs and former director of a registered charity, Jump Math. Mr. Goodall has an HBA from the Ivey Business School, and an MBA from the Schulich School of Business.

Kent Willmore

President
AGinvest Farmland Properties Canada
Ontario Farmland

Kent has over 30 years of experience in the agricultural field. He grew up in a farm family and has been buying and operating farms for his own account since 2001. In addition to his role at AGinvest, Kent is the owner of WR Detasseling Ltd. and Willmore Farms Ltd. Kent developed WR Detasseling Ltd. into Canada’s largest contract seed corn service provider, with its customer list including DuPont Pioneer, Monsanto, Pride Seeds, Maizex Seeds, Horizon Seeds, CL Seeds, Glenn Seeds and Syngenta Canada. Kent also established Willmore Farms Ltd, a farming company that produces crops on his personal portfolio of Ontario farmland. He holds a Bachelor of Arts in Environmental Science from the University of Waterloo, and a Bachelor of Education from the University of Windsor with an all-Canadian academic athlete designation.

Gil Aharon

Co-founder and Portfolio Manager
Rosalind Advisors
Health Science/Biotech

Portfolio manager at Rosalind Advisors, Inc. which he co-founded, along with Steven Salamon, in 2006.

Ranked as #1 North American sell-side biotech analyst as of July 2006, by industry excess return, based on StarMine.

Conducted a collaborative research project, at the Rotman School of Management, studying the complimentary relation between financial and non-financial information in explaining prices, equity returns and the degree of investor sophistication in the biotechnology sector.

Intellectual property from doctoral work formed the basis for the creation of a publicly-traded California-based biotechnology company.

Ph.D. with a focus on biophysics and molecular biology from the University of Toronto.